Healthcare -
Biotechnology - NASDAQ - US
$ 6.58
-0.303 %
$ 326 M
Market Cap
-1.31
P/E
RGNX - TOTAL CURRENT LIABILITIES
Total Current Liabilities RGNX - REGENXBIO Inc.
130 M
LAST VALUE
-0.08%
2 YEAR CAGR
42.49%
5 YEAR CAGR
39.54%
10 YEAR CAGR